USPTO serial 79179512
RTM
Reviewed by CopyMark Law Group
Reg. 5238541Status 708Renewal
- Filing date
- Status date
- Registration date
- Jul 11, 2017
- Examiner
- VALLILLO, MELISSA C
- Law office
- —
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RTM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janice Housey
Janice Housey Litmus Law PLLC4 Weems Lane #240Winchester, VA 22601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals used in industry; chemical preparations for industrial purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposes, namely, cell cultures, tissue cultures, chemical and biological assays; biological preparations for use in cell cultures other than for medical or veterinary use; peptides for chemical products and foodstuffs, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; polypeptides for use in diagnostic and therapeutic agents except for medical or veterinary use; antibodies and proteins for scientific use ] | SECTION 71 - CANCELLED | — |
| 005 | [ Pharmaceutical preparations for use in the treatment of diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations for use in the treatment of diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for the removal of tumors; pharmaceutical preparations for neurodegenerative diseases; pharmaceutical preparations, namely, immunogens for medical use; vaccines, diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological disease; epitopes for pharmaceutical use for use in attaching to antibodies for in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological disease; peptides for pharmaceutical purposes for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biological preparations for medical use, namely, pharmaceutical preparations for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biocides; diagnostic products, namely, diagnostic preparations for medical and veterinary use; pre-moistened medicated towels for hygiene purposes; dietetic foods, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes, namely, dietetic bread and dietetic noodles; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, namely, dietetic tea adapted for medical use; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes, namely, low calorie or reduced calorie fruit beverages; protein antibodies for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing ] | SECTION 71 - CANCELLED | — |
| 042 | [ Monitoring and inspection for the quality control and scientific analysis of active substances; ] pharmaceutical research; [ scientific research in the field of cosmetics and foodstuffs; consultancy and information on monitoring and inspection for the quality control and scientific analysis of active substances; ] scientific consultation relating to research involving pharmaceutical products; [ scientific consultation relating to research in the field of cosmetics and foodstuffs; monitoring and inspection for the quality control and scientific analysis of active substances; ] scientific research involving medical treatment and methods; scientific research in the fields of biotechnology and antibodies; [ information on monitoring and inspection for the quality control and scientific analysis of active substance; ] scientific testing and research in technical and medical treatment relating to active substances; [ scientific research in the field of sanitary care; ] scientific monitoring, inspection and research in the field of biology; consultancy and provision of information relating to quality control of pharmaceutical preparations; [ software maintenance, computer software design, computer programming; design and development of computer hardware; software development; software maintenance; ] all of the foregoing related to pharmaceutical preparations, medical and veterinary purposes and related to the treatment, diagnosis and prevention of human diseases | ACTIVE | — |
| 044 | [ Medical services; medical services in the field of immunity; provision of medical information; medical examinations; preparation and dispensing of medicines; nutritional consultancy and dietary consultancy relating to nutrition; medical consultancy and provision of medical information in the field of sanitary care; veterinary services, namely, veterinary assistance; beauty salon services; veterinary care services for animals; hygienic care; consultancy and provision of information relating to the dispensing and preparation of pharmaceutical preparations ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RTM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 11, 2026 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jul 10, 2025 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 12, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 12, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 12, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 6, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 20, 2024 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 20, 2024 | INPC | INVALIDATION PROCESSED | — |
| Mar 12, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 12, 2023 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jul 12, 2023 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jul 4, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 15, 2022 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 4, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 31, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 3, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 16, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 16, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 11, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 11, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2017 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 31, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 31, 2017 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 25, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 22, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 5, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 5, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 5, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 20, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 15, 2017 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 15, 2017 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Mar 15, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 15, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 15, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 13, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 13, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2017 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 7, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 6, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jan 19, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 19, 2017 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jan 19, 2017 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 19, 2017 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 19, 2016 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 19, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 23, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 4, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 1, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 11, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 11, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 8, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 6, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 5, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 4, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |